Case Report: Probable Cerebral Amyloid Angiopathy-Related Inflammation During Bevacizumab Treatment for Metastatic Cervical Cancer

Bevacizumab is an anti-angiogenic monoclonal antibody targeting Vascular Endothelial Growth Factor (VEGF) that induces the proliferation and migration of vascular endothelial cells thus, promoting vasculogenesis. Bevacizumab inhibits cancer angiogenesis, which is fundamental for either tumor develop...

Descripción completa

Detalles Bibliográficos
Autores principales: Koudriavtseva, Tatiana, Lorenzano, Svetlana, Anelli, Vincenzo, Sergi, Domenico, Stefanile, Annunziata, Di Domenico, Enea Gino, Maschio, Marta, Galiè, Edvina, Piantadosi, Carlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353446/
https://www.ncbi.nlm.nih.gov/pubmed/34386418
http://dx.doi.org/10.3389/fonc.2021.669753

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353446/
https://www.ncbi.nlm.nih.gov/pubmed/34386418
http://dx.doi.org/10.3389/fonc.2021.669753

Ejemplares similares